Cancer cells compress intratumour vessels
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The delivery of therapeutic drugs to solid tumours may be impaired by structural and functional abnormalities in blood and lymphatic vessels. Here we provide evidence that proliferating cancer cells cause intratumour vessels to compress and collapse. By reducing this compressive mechanical force and opening vessels, cytotoxic cancer treatments have the potential to increase blood perfusion, thereby improving drug delivery.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This results in uneven blood flow within the tumor, generating regions of chronic or intermittent hypoxia and regions of enhanced permeability and increased interstitial pressure, which can result in compression of tumor vessels and poor vascular perfusion, hampering drug delivery [27].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [27]
In the citing paper
“It enhances tumor cell proliferation and builds up a transport barrier to drug delivery, greatly lowering the efficacy of anticancer drugs and therapies.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [171]
In the citing paper
“Elevated extracellular stresses have been observed in many tumors[170][171][172][173][174][175][176][177][178].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [171]
Citations
Cites
Molecular regulation of vessel maturation
Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,529
Self-citationLymphatic Metastasis in the Absence of Functional Intratumor Lymphatics
Padera, T. P., Kadambi, A., di Tomaso, E., Carreira, C. M., Brown, E. B., Boucher, Y., Choi, N. C., Mathisen, D., Wain, J., Mark, E. J., et al. (2002) · Science · doi:10.1126/science.1071420 · Cited by 967
Self-citationSolid stress inhibits the growth of multicellular tumor spheroids
Helmlinger, G., Netti, P. A., Lichtenbeld, H. C., Melder, R. J., & Jain, R. K. (1997) · Nature Biotechnology · doi:10.1038/nbt0897-778 · Cited by 859
Self-citationMolecular mechanisms of lymphangiogenesis in health and disease
Alitalo, K., & Carmeliet, P. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00051-x · Cited by 734
Boucher, Y., & Jain, R. K. (1992) · PubMed · Cited by 510
Self-citation(1999) · PubMed · Cited by 348
Self-citationThe Second Valve System in Lymphatics
Schmid-Schönbein, G. W. (2003) · Lymphatic Research and Biology · doi:10.1089/15396850360495664 · Cited by 113
Solid stress facilitates spheroid formation: potential involvement of hyaluronan
Koike, C., McKee, T. D., Pluen, A., Ramanujan, S., Burton, K., Munn, L. L., Boucher, Y., & Jain, R. K. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600158 · Cited by 83
Self-citationImproved microcirculation in irradiated tumours
Reinhold, H. S. (1971) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(71)90069-7 · Cited by 71
Arbiser, J. L., Raab, G., Rohan, R. M., Paul, S., Hirschi, K. K., Flynn, E. A., Price, E. R., Fisher, D. E., Cohen, C., & Klagsbrun, M. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65171-1 · Cited by 36
Research works printed but not linked: 2
- Boucher, Y. & Jain, R. K. Cancer Res. 52, 5110–5114 (1992).
- Griffon-Etienne, G., Boucher, Y., Brekken, C., Suit, H. D. & Jain, R. K. Cancer Res. 59, 3776–3782 (1999).
Cited by
Items 201–300 of 859
Voutouri, C., Kirkpatrick, N. D., Chung, E., Mpekris, F., Baish, J. W., Munn, L. L., Fukumura, D., Stylianopoulos, T., & Jain, R. K. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818322116 · Cited by 111
Self-citationMicrowave‐induced thermoacoustic scanning CT for high‐contrast and noninvasive breast cancer imaging
Nie, L., Xing, D., Zhou, Q., Yang, D., & Guo, H. (2008) · Medical Physics · doi:10.1118/1.2966345 · Cited by 100
Grizzi, F., Russo, C., Colombo, P., Franceschini, B., Frezza, E. E., Cobos, E., & Chiriva‐Internati, M. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-14 · Cited by 100
“the environment) may be loosened [18], thus altering not only the number of vessels but also the whole vascular architecture [15,38].”
BackgroundQuantifying solid stress and elastic energy from excised or in situ tumors
Nia, H. T., Datta, M., Seano, G., Huang, P., Munn, L. L., & Jain, R. K. (2018) · Nature Protocols · doi:10.1038/nprot.2018.020 · Cited by 101
Self-citationHypoxia, notch signalling, and prostate cancer
Marignol, L. H., Rivera-Figueroa, K., Lynch, T. H., & Hollywood, D. P. (2013) · Nature Reviews Urology · doi:10.1038/nrurol.2013.110 · Cited by 102
Snipstad, S., Berg, S., Mørch, Y. A., Bjørkøy, A., Sulheim, E., Hansen, R., Grimstad, I. H., van Wamel, A. J. E. T., Maaland, A. F., TORP, S. H., et al. (2017) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2017.06.029 · Cited by 103
“…Desai 2012), such as the heterogeneous EPR effect between and within tumors (Hansen et al. 2015; He et al. 2015; Maeda 2015; Prabhakar et al. 2013), poor vascularization, high interstitial fluid pressure, high tumor cell density (Padera et al. 2004) and dense ECM (Chauhan et al. 2011; Desai 2012).”
BackgroundSolid stress impairs lymphocyte infiltration into lymph-node metastases
Jones, D., Wang, Z., Chen, I. X., Zhang, S., Banerji, R., Lei, P., Zhou, H., Xiao, V., Kwong, C., van Wijnbergen, J. W., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00766-1 · Cited by 98
Self-citationWu, P., Han, J., Gong, Y., Liu, C., Yu, H., & Xie, N. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14101990 · Cited by 111
“In addition, the abnormal vasculature impairs the transportation of nutrition and O2 by decreasing blood flow due to the tumor cells’ excessive growth [147].”
BackgroundSinek, J. P., Frieboes, H. B., Zheng, X., & Vittorio Cristini, C. (2004) · Biomedical Microdevices · doi:10.1023/b:bmmd.0000048562.29657.64 · Cited by 95
Levayer, R. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.05.004 · Cited by 108
Minicells: Versatile vectors for targeted drug or si/shRNA cancer therapy
MacDiarmid, J. A., & Brahmbhatt, H. N. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.04.008 · Cited by 96
Minagawa, Y., Shizukuishi, K., Koike, I., Horiuchi, C., Watanuki, K., Hata, M., Omura, M., Odagiri, K., Tohnai, I., Inoue, T., et al. (2011) · Annals of Nuclear Medicine · doi:10.1007/s12149-011-0471-5 · Cited by 92
Wagner, M., Bjerkvig, R., Wiig, H., Melero-Martin, J. M., Lin, R.-Z., Klagsbrun, M., & Dudley, A. C. (2012) · Angiogenesis · doi:10.1007/s10456-012-9276-y · Cited by 91
“Similar to what occurs in tumor blood vessels [39, 40], biomechanical forces created by the growing mass of tumor cells may ‘‘squeeze’’ the tumorassociated adipocytes resulting in distortion of cellular membranes and rupture.”
BackgroundLazzari, G., Vinciguerra, D., Balasso, A., Nicolas, V., Goudin, N., Garfa‐Traoré, M., Fehér, A., Dinnyés, A., Nicolas, J., Couvreur, P., et al. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.06.019 · Cited by 98
Guo, J. X., Zeng, H., & Chen, Y. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00014 · Cited by 99
Mesenchymal stem cells: A living carrier for active tumor-targeted delivery
Zhang, T., Lin, R., Wu, H., Jiang, X., & Gao, J. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114300 · Cited by 95
Camara, O., Rengsberger, M., Egbe, A., Koch, A., Gajda, M. R., Hammer, U., Jörke, C., Rabenstein, C., Untch, M., & Pachmann, K. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm206 · Cited by 90
Magnetically assisted intraperitoneal drug delivery for cancer chemotherapy
Shamsi, M., Sedaghatkish, A., Dejam, M., Saghafian, M., Mohammadi, M., & Sanati‐Nezhad, A. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1455764 · Cited by 94
“The lymphatic term is also set to zero inside the tumor due to the absence of functional lymphatics (Padera et al., 2004; Jain et al., 2014).”
BackgroundThermographic assessment of tumor growth in mouse xenografts
Song, C., Appleyard, V. C. L., Murray, K. E., Frank, T., Sibbett, W., Cuschieri, A., & Thompson, A. M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22808 · Cited by 88
Dickie, R., Bachoo, R. M., Rupnick, M. A., Dallabrida, S. M., DeLoid, G. M., Lai, J., DePinho, R. A., & Rogers, R. A. (2006) · Microvascular Research · doi:10.1016/j.mvr.2006.05.003 · Cited by 93
Ozcelikkale, A., Moon, H., Linnes, M., & Han, B. (2017) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1460 · Cited by 87
Molecular imaging strategies for drug discovery and development
Gross, S., & Piwnica-Worms, D. R. (2006) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2006.06.028 · Cited by 95
Nie, L., Ou, Z., Yang, S., & Xing, D. (2010) · Medical Physics · doi:10.1118/1.3466696 · Cited by 86
Predicting drug pharmacokinetics and effect in vascularized tumors using computer simulation
Sinek, J. P., Sanga, S., Zheng, X., Frieboes, H. B., Ferrari, M., & Cristini, V. (2008) · Journal of Mathematical Biology · doi:10.1007/s00285-008-0214-y · Cited by 93
“Atop this intrinsic heterogeneity is layered the anatomical and functional irregularity of tumoral vasculature, characterized by erratic flow, collapsed vessels, diminished oxygen tension, and a large mean tissue-to-vessel distance [5,29,30,34, 54].”
BackgroundMarcucci, F., & Corti, A. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.09.007 · Cited by 94
Nathan, S. S., DiResta, G. R., Casas-Ganem, J. E., Hoang, B. H., Sowers, R., Yang, R., Huvos, A. G., Gorlick, R., & Healey, J. H. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2048 · Cited by 85
Light-Chain 3A Autophagic Activity and Prognostic Significance in Non-small Cell Lung Carcinomas
Karpathiou, G., Sivridis, E., Koukourakis, M. I., Mikroulis, D. A., Bouros, D. E., Froudarakis, Μ. E., & Giatromanolaki, A. N. (2010) · CHEST Journal · doi:10.1378/chest.10-1831 · Cited by 88
Lymphatic vessels in health and disease
Kesler, C. T., Liao, S., Munn, L. L., & Padera, T. P. (2013) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1201 · Cited by 83
Self-citationBotulinum toxin potentiates cancer radiotherapy and chemotherapy.
Ansiaux, R., Baudelet, C., Cron, G. O., Segers, J., Dessy, C., Martinive, P., Wever, J. D., Verrax, J., Wauthier, V., Beghein, N., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1222 · Cited by 90
Mechanical factors activate ß‐catenin‐dependent oncogene expression in APC1638N/+mouse colon
Whitehead, J., Vignjevic, D., Fütterer, C., Beaurepaire, E., Robine, S., & Farge, E. (2008) · HFSP Journal · doi:10.2976/1.2955566 · Cited by 81
“…one can imagine that once initiated, tumor progression may be further accelerated by mechanical signals resulting from the tumor growth itself, such as inappropriate proliferation, elevated interstitial fluid pressure, fibrosis, or loss of elasticity (Padera et al., 2004; Paszek et al., 2005).”
BackgroundIntermittent Hypoxia Regulates Stem-like Characteristics and Differentiation of Neuroblastoma Cells
Bhaskara, V. K., Mohanam, I., Rao, J. S., & Mohanam, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030905 · Cited by 79
“Most solid tumors exhibit regions of hypoxia as a result of inefficient vascular supply by tumor vasculature and high oxygen consumption of rapidly proliferating malignant cells [4–6].”
BackgroundHe, G., Chen, S., Xu, Y., Miao, Z., Ma, Y., Qian, H., Lü, Y., & Zha, Z. (2019) · Materials Horizons · doi:10.1039/c9mh00020h · Cited by 80
Fluorescence Guidance in Surgical Oncology: Challenges, Opportunities, and Translation
Olson, M. T., Ly, Q. P., & Mohs, A. M. (2018) · Molecular Imaging and Biology · doi:10.1007/s11307-018-1239-2 · Cited by 90
Present and future of cancer immunotherapy: A tumor microenvironmental perspective (Review)
Yu, Y., & Cui, J. (2018) · Oncology Letters · doi:10.3892/ol.2018.9219 · Cited by 109
“…by proliferating tumor cells compresses intratumor blood and lymphatic vessels, which further impairs not only the blood flow, but also the lymphatic flow (39); therefore, the heterogeneity in the stroma of tumor microenvironment requires consideration regarding the efficacy of immunotherapies.”
Aspriţoiu, V. M., Stoica, I., Bleoţu, C., & Diaconu, C. C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.689962 · Cited by 90
Integrative models of vascular remodeling during tumor growth
Rieger, H., & Welter, M. (2015) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1295 · Cited by 87
“WIREs Systems Biology and Medicine published by Wiley Periodicals, Inc.”
BackgroundMultiscale Measurements Distinguish Cellular and Interstitial Hindrances to Diffusion In Vivo
Chauhan, V. P., Lanning, R. M., Diop-Frimpong, B., Mok, W., Brown, E. B., Padera, T. P., Boucher, Y., & Jain, R. K. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.03.064 · Cited by 77
Self-citationBioengineered tumoral microtissues recapitulate desmoplastic reaction of pancreatic cancer
Brancato, V., Comunanza, V., Imparato, G., Corà, D., Urciuolo, F., Noghero, A., Bussolino, F., & Netti, P. A. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.11.072 · Cited by 82
“Furthermore, the aberrant fibrotic reaction compresses vessels thus limiting perfusion with consequent poor drug delivery [25,26].”
Multifunctional platinum‐based nanoparticles for biomedical applications
Cheng, Q., & Liu, Y. (2017) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1410 · Cited by 76
Tracer kinetic model–driven registration for dynamic contrast‐enhanced MRI time‐series data
Buonaccorsi, G. A., O’Connor, J. P. B., Caunce, A., Roberts, C., Cheung, S., Watson, Y., Davies, K. E., Hope, L., Jackson, A., Jayson, G. C., et al. (2007) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21405 · Cited by 75
Thoeny, H. C., Keyzer, F. D., Chen, F., Vandecaveye, V., Verbeken, E. K., Ahmed, B., Sun, X., Ni, Y., Bosmans, H., Hermans, R., et al. (2005) · Neoplasia · doi:10.1593/neo.04748 · Cited by 75
“Very recently, preclinical in vivo data have been published on the impact of cell density on the potential of microvessels to provide adequate intratumoral perfusion [37].”
BackgroundLiao, S., Liu, J., Lin, P., Shi, T., Jain, R. K., & Xu, L. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2429 · Cited by 73
Self-citationBöckelmann, L. C., & Schumacher, U. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1702974 · Cited by 72
Phosphorescent NIR emitters for biomedicine: applications, advances and challenges
Chelushkin, P. S., Shakirova, J. R., Kritchenkov, I. S., Baigildin, V. A., & Tunik, S. P. (2021) · Dalton Transactions · doi:10.1039/d1dt03077a · Cited by 74
Targeting extracellular matrix stiffness for cancer therapy
Feng, X., Cao, F., Wu, X., Xie, W., Wang, P., & Jiang, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1467602 · Cited by 87
Kidoya, H., Kunii, N., Naito, H., Muramatsu, F., Okamoto, Y., Nakayama, T., & Takakura, N. (2011) · Oncogene · doi:10.1038/onc.2011.489 · Cited by 80
Friedman, D., Simmonds, P., Hale, A., Bere, L., Hodson, N. W., White, M. R. H., & Davis, D. M. (2021) · Journal of Cell Science · doi:10.1242/jcs.258570 · Cited by 70
“These changes depend on several factors including dysregulated vasculature and variation in the extracellular matrix composition (Padera et al., 2004; Muiznieks and Keeley, 2013).”
BackgroundGlioblastoma: To Target the Tumor Cell or the Microenvironment?
Vleeschouwer, S. D., & Bergers, G. (2017) · Codon Publications eBooks · doi:10.15586/codon.glioblastoma.2017.ch16 · Cited by 82
Wu, J., Long, Q., Xu, S., & Padhani, A. R. (2009) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2009.01.009 · Cited by 72
Recent advances in gold and silver nanoparticle based therapies for lung and breast cancers
Malik, P., & Mukherjee, T. K. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.10.048 · Cited by 73
Biological rationale for the design of polymeric anti-cancer nanomedicines
Zhou, Y., & Kopec̆ek, J. (2012) · Journal of drug targeting · doi:10.3109/1061186x.2012.723213 · Cited by 72
“In some cases such as desmoplasia, the highly proliferating cancer cells and stromal cells compress the tumor blood vessels, causing blood vessel collapse (Padera et al., 2004).”
BackgroundZhu, Y., Wen, L., Shao, S., Tan, Y., Meng, T., Yang, X., Liu, Y., Liu, X., Yuan, H., & Hu, F. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.023 · Cited by 66
Extravasating Neutrophils Open Vascular Barrier and Improve Liposomes Delivery to Tumors
Naumenko, V. A., Vlasova, K. Y., Garanina, A. S., Melnikov, P. A., Potashnikova, D. M., Vishnevskiy, D. A., Vodopyanov, S. S., Chekhonin, V. P., Abakumov, M. A., & Majouga, A. G. (2019) · ACS Nano · doi:10.1021/acsnano.9b03848 · Cited by 66
Toffoli, S., Féron, O., Raes, M. J., & Michiels, C. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.06.002 · Cited by 78
Use of H215O-PET and DCE-MRI to Measure Tumor Blood Flow
de Langen, A. J., van den Boogaart, V., Marcus, J. T., & Lubberink, M. (2008) · The Oncologist · doi:10.1634/theoncologist.2007-0235 · Cited by 78
“Areas of dilated, tortuous, and leaky vessels exist together with less abnormal areas [6, 7]. Interstitial hypertension, caused by vascular hyperpermeability and mechanical stress of lymphatics by tumor cell growth, can lead to blood flow stasis or even retrograde flow in tumors [ 8 , 9]. This results in hypoxia and a…”
BackgroundLymphatic Vessels in Tumor Dissemination versus Immunotherapy
Vaahtomeri, K., & Alitalo, K. K. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0156 · Cited by 68
“However, the growing primary tumor causes compression of the intratumoral lymphatic vessels, which leads to compromised flow of fluid and macromolecules and, thus, increased interstitial fluid pressure in the tumor (5).”
BackgroundVEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy
Greenberg, J. I., & Cheresh, D. A. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903208883 · Cited by 70
“Human studies using both noninvasive imaging and careful histological analyses have demonstrated the rapid targeting of immature blood vessels by anti-VEGF therapy ushering in the appearance of a more mature tumor vascular network [49].”
BackgroundZhang, S., Grifno, G. N., Passaro, R., Regan, K., Zheng, S., Hadzipasic, M., Banerji, R., O’Connor, L., Chu, V., Kim, S. Y., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01080-8 · Cited by 67
“In both human and murine breast cancer lung metastasis, a hallmark of the physical microenvironment is solid stress accumulation resulting in vessel compression 12,14 .”
BackgroundA two-tiered physiologically based model for dually labeled single-chain Fv-Fc antibody fragments
Ferl, G. Z., Kenanova, V. E., Wu, A. M., & DiStefano, J. J. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0072 · Cited by 64
“ing lymphatic system is typically not present within intratumor regions (35).”
BackgroundTahara, Y., Yoshikawa, T., Sato, H., Mori, Y., Zahangir, M. H., Kishimura, A., Mori, T., & Katayama, Y. (2017) · MedChemComm · doi:10.1039/c6md00614k · Cited by 63
Sentinel lymph node metastases in cancer: Causes, detection and their role in disease progression
Nathanson, S. D., Shah, R. A., & Rosso, K. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.10.002 · Cited by 69
Brurberg, K. G., Skogmo, H. K., Graff, B. A., Olsen, D. R., & Rofstad, E. K. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2005.09.009 · Cited by 62
“For example, the mechanical pressure against microvascular walls is reduced after irradiation, because tumor cells are inactivated and undergo apoptotic or mitotic death [15].”
BackgroundGeretti, E., Leonard, S. C., Dumont, N., Lee, H., Zheng, J., De Souza, R., Gaddy, D. F., Espelin, C. W., Jaffray, D. A., Moyo, V., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0314 · Cited by 61
“Uncontrolled tumor cell growth indirectly affects vasculature function by compressing and collapsing tumor blood vessels (23, 24).”
BackgroundLiang, C., Zhang, X., Yang, M., Wang, W., Chen, P., & Dong, X. (2020) · ACS Materials Letters · doi:10.1021/acsmaterialslett.0c00259 · Cited by 62
Evolution of osmotic pressure in solid tumors
Voutouri, C., & Stylianopoulos, T. (2014) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2014.09.019 · Cited by 68
“These stresses are also applied to intratumoral blood vessels causing their compression (Padera et al., 2004; Stylianopoulos et al., 2013).”
BackgroundCooperative tumour cell membrane targeted phototherapy
Kim, H., Lee, J., Oh, C., & Park, J. (2017) · Nature Communications · doi:10.1038/ncomms15880 · Cited by 65
“The peripheral regions where blood vessels are relatively permeable and the interstitial regions where blood vessels are often collapsed under high interstitial fluid pressure were specifically observed to compare the accumulation and distribution patterns 31 .”
Normalizing tumor microenvironment with nanomedicine and metronomic therapy to improve immunotherapy
Mpekris, F., Voutouri, C., Panagi, M., Baish, J. W., Jain, R. K., & Stylianopoulos, T. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.008 · Cited by 62
Self-citationPathak, A. P., Artemov, D., Ward, B. D., Jackson, D. G., Neeman, M., & Bhujwalla, Z. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3682 · Cited by 59
“In tumors, lymphatics have either been shown to be poorly developed (4) or nonfunctional due to the existing mechanical stresses (5), with the result that the transport of macromolecules and cell debris through the extracellular matrix are thought to occur primarily via convective flow (6, 7).”
BackgroundSmooth Muscle Tension Induces Invasive Remodeling of the Zebrafish Intestine
Seiler, C., Davuluri, G., Abrams, J., Byfield, F. J., Janmey, P. A., & Pack, M. A. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001386 · Cited by 68
“increases interstitial pressure within the tumor itself [10,11], which”
BackgroundModulating tumor physical microenvironment for fueling CAR-T cell therapy
Luo, Z. Y., Yao, X., Li, M., Fang, D., Fei, Y., Cheng, Z., Xu, Y., & Zhu, B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114301 · Cited by 62
Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer
Sarvari, P., Sarvari, P., Ramírez‐Díaz, I., Mahjoubi, F., & Rubio, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179521 · Cited by 74
Vessel calibre—a potential MRI biomarker of tumour response in clinical trials
Emblem, K. E., Farrar, C. T., Gerstner, E. R., Batchelor, T. T., Borra, R. J. H., Rosen, B. R., Sorensen, A. G., & Jain, R. K. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.126 · Cited by 59
Self-citationUsing mathematical modelling and AI to improve delivery and efficacy of therapies in cancer
Harkos, C., Hadjigeorgiou, A. G., Voutouri, C., Kumar, A. S., Stylianopoulos, T., & Jain, R. K. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00796-w · Cited by 80
Self-citationUnderstanding nano-bio interactions to improve nanocarriers for drug delivery
Pearson, R. M., Hsu, H.-J., Bugno, J., & Hong, S. (2014) · MRS Bulletin · doi:10.1557/mrs.2014.9 · Cited by 57
Mechanical strain induces involution-associated events in mammary epithelial cells
Quaglino, A., Salierno, M. J., Pellegrotti, J. V., Rubinstein, N., & Kordon, E. C. (2009) · BMC Cell Biology · doi:10.1186/1471-2121-10-55 · Cited by 61
“For example, it has been demonstrated that in solid tumors, cells are subjected to mechanical stress due to elevated interstitial pressure and perturbed vasculature [6].”
Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors
Zhang, X., Milito, A. D., Olofsson, A. M., Gullbo, J., D’Arcy, P., & Linder, S. T. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161126020 · Cited by 59
“The vasculature at the tumor site is generally poorly organized [11] with a high degree of compression on the supplying blood vessels, leading to the disrupted flow of nutrients and oxygen to the tumor tissue [12].”
BackgroundKumar, V., Boucher, Y., Liu, H., Ferreira, D., Hooker, J., Catana, C., Hoover, A. J., Ritter, T., Jain, R. K., & Guimaraes, A. R. (2016) · Translational Oncology · doi:10.1016/j.tranon.2016.07.004 · Cited by 57
Self-citationMechanoregulation of Vascular Endothelial Growth Factor Receptor 2 in Angiogenesis
Miller, B., & Sewell-Loftin, M. K. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.804934 · Cited by 60
Lymphangiogenesis in colorectal cancer—Prognostic and therapeutic aspects
Sundlisæter, E., Dicko, A., Sakariassen, P. Ø., Søndenaa, K., Enger, P. Ø., & Bjerkvig, R. (2007) · International Journal of Cancer · doi:10.1002/ijc.22996 · Cited by 60
Helfrich, I., & Schadendorf, D. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.01.003 · Cited by 67
Lièvre, A., Samalin, E., Mitry, E., Assénat, E., Gestin-Boyer, C., Lepère, C., Bachet, J., Portales, F., Vaillant, J.-N., Ychou, M., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-347 · Cited by 60
“Tumor vasculature is structurally and functionally abnormal, which results in an heterogeneity in tumor blood flow with interstitial hypertension, hypoxia and acidosis [27].”
Kirkpatrick, N. D., Chung, E., Cook, D., Han, X., Gruionu, G., Liao, S., Munn, L. L., Padera, T. P., Fukumura, D., & Jain, R. K. (2012) · IntraVital · doi:10.4161/intv.21557 · Cited by 56
Self-citationAngiogenesis inhibition with bevacizumab and the surgical management of colorectal cancer
Thornton, A. D., Ravn, P., Winslet, M. C., & Chester, K. A. (2006) · British journal of surgery · doi:10.1002/bjs.5624 · Cited by 55
The Role of Lymph Node Metastasis in the Systemic Dissemination of Breast Cancer
Nathanson, D. S., Kwon, D., Kapke, A., Alford, S. H., & Chitale, D. A. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0659-2 · Cited by 64
“open despite the increased pressure and mechanically enhance the intravasation of fluid and tumor cells.(28,32) The low-shear lymphatic system is also less likely to cause mechanical destruction of tumor cells than the high-shear blood circulation.”
Ozcelikkale, A., Ghosh, S., & Han, B. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3005947 · Cited by 55
Tadeo, I., Berbegall, A. P., Castel, V., García‐Miguel, P., Callaghan, R. C., Påhlman, S., Navarro, S., & Noguera, R. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.210 · Cited by 57
“The compression of tumour vasculature also leads to a reduction in tumour blood flow and subsequently reduces the anticancer agent transport to tumour cells (Padera et al, 2004).”
BackgroundContrast‐enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor‐bearing mice
Zong, Y., Wang, X., Goodrich, K. C., Mohs, A. M., Parker, D. L., & Lu, Z. (2005) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20402 · Cited by 55
Advanced Biomaterials for Cell‐Specific Modulation and Restore of Cancer Immunotherapy
Ruan, S., Huang, Y., He, M., & Gao, H. (2022) · Advanced Science · doi:10.1002/advs.202200027 · Cited by 56
Sasahira, T., Kirita, T., Kurihara, M., Yamamoto, K., BHAWAL, U. K., Bosserhoff, A., & Kuniyasu, H. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.04.027 · Cited by 56
Ziaee, N., Farhadian, N., Abnous, K., Matin, M. M., Khoshnood, A., & Yaghoobi, E. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114971 · Cited by 53
Wang, J., Guo, Y., Wang, B., Bi, J., Li, K., Liang, X., Chu, H., & Jiang, H. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-2024-y · Cited by 56
“However, others studies found that intratumoural lymphatics may be non-functional because cancer progression causes lymphatic destruction [80, 86, 87], implying that lymphangiogenesis plays little role in facilitating primary tumor dissemination.”
Yoshikawa, T., Mori, Y., Feng, H., Phan, K. Q., Kishimura, A., Kang, J., Mori, T., & Katayama, Y. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.05.043 · Cited by 55
Probing the physical hallmarks of cancer
Nia, H. T., Munn, L. L., & Jain, R. K. (2025) · Nature Methods · doi:10.1038/s41592-024-02564-4 · Cited by 62
“It was quickly realized that such stresses exist in vivo and that they are sufficiently large to compress and impair blood and lymphatic vessels 12 .”
Self-citationAntiangiogenic therapy: Markers of response, “normalization” and resistance
Alaoui‐Lasmaili, K. E., & Faivre‐Fiorina, B. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.06.001 · Cited by 55
Lu, Z., Mohs, A. M., Zong, Y., & Feng, Y. (2006) · International Journal of Nanomedicine · doi:10.2147/nano.2006.1.1.31 · Cited by 52
“…effective contrast enhancement than GDCC. Contrast enhancement in the tumor interstitium was less significant, possibly due to high interstitial fluid pressure, collapsed blood vessels forced by rapidly growing tumor tissue, and the formation of necrotic tissue in solid tumor (Padera et al 2004).”
Tombari, C., Zannini, A., Bertolio, R., Pedretti, S., Audano, M., Triboli, L., Cancila, V., Vacca, D., Caputo, M., Donzelli, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42458-1 · Cited by 60
Modulating cancer mechanopathology to restore vascular function and enhance immunotherapy
Mpekris, F., Panagi, M., Charalambous, A., Voutouri, C., & Stylianopoulos, T. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101626 · Cited by 78
A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor
Chabot, S., Jabrane‐Ferrat, N., Bigot, K., Tabiasco, J., Provost, A. C., Golzio, M., Noman, M. Z., Giustiniani, J., Bellard, E., Brayer, S., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20100810 · Cited by 52
“Mature vessels are more resistant to the pressure exerted by proliferating tumors, favoring drug delivery within the tumor (Padera et al., 2004).”
BackgroundEGFR-Targeted Polymeric Mixed Micelles Carrying Gemcitabine for Treating Pancreatic Cancer
Mondal, G., Kumar, V., Shukla, S. K., Singh, P. K., & Mahato, R. I. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b01419 · Cited by 56
Pathak, A. P., Artemov, D., Neeman, M., & Bhujwalla, Z. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1788 · Cited by 56
“In addition, factors such as elevated interstitial fluid pressure, blood vessel permeability, hydraulic conductivity, blood pressure (19), and the pressure exerted by proliferating cancer cells (20) have each been known to affect the intratumoral transport of macromolecules.”
Metadata
- Authors
- Padera, T. P., Stoll, B. R., Tooredman, J. B., Capen, D., Tomaso, E. D., & Jain, R. K.
- Affiliations
- Harvard University (US)
- Corresponding author
- Jain, Rakesh K.
- Venue
- Nature
- Published
- 2004-02-19
- Volume
- 427
- Issue
- 6976
- Pages
- 695-695
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2014282546
- Cited by
- 857
- References
- 10
- Citations by year
- 2026: 28 · 2025: 48 · 2024: 40 · 2023: 47 · 2022: 39 · 2021: 44 · 2020: 48 · 2019: 48 · 2018: 37 · 2017: 57 · 2016: 48 · 2015: 32 · 2014: 36 · 2013: 39 · 2012: 42
- FWCI
- 12.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- tumor vasculature, tumor cell proliferation, vascular collapse, mechanical forces, lymphatic vessels, cytotoxic chemotherapy
- MeSH terms
- Animals, Cell Division, Diphtheria Toxin, Humans, Neoplasm Transplantation, Neoplasms, Transplantation, Heterologous, Reperfusion, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.